Nkarta NKTX
NASDAQ NKTX
$2.66 +0.19 (+7.69%)
At close: Aug 21, 2026 · 4:00 PM EDT

Nkarta (NKTX) Cash from Investing Activities (2019 - 2026)

Nkarta (NKTX) posted quarterly Cash from Investing Activities of $15.9 million for Q1 2026, down 70.71% year-over-year from $54.3 million in Q1 2025, and up 1342.88% quarter-over-quarter from $1.1 million in Q4 2025.

Nkarta (NKTX) Cash from Investing Activities (2019 - 2026) Analysis & Trends

Nkarta's Cash from Investing Activities history runs 8 years deep, the most recent figure standing at $15.9 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities fell 70.71% year-over-year to $15.9 million; the TTM figure through Mar 2026 stood at $61.9 million (up 164.01% YoY), while the FY2025 annual figure was $100.3 million, up 177.43% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at $15.9 million, up from $1.1 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $54.3 million in Q1 2025, with the low at -$109.3 million in Q2 2022.
  • The 5-year median for Cash from Investing Activities is $4.7 million (2022), against an average of -$7.0 million.
  • The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities jumped 3699.32% in 2023, then tumbled 3294.04% in 2024.
  • Nkarta's Cash from Investing Activities stood at $4.7 million in 2022, then surged by 233.62% to $15.8 million in 2023, then sank by 128.54% to -$4.5 million in 2024, then surged by 124.4% to $1.1 million in 2025, then jumped by 1342.88% to $15.9 million in 2026.
  • Business Quant data shows NKTX's Cash from Investing Activities at $15.9 million in Q1 2026, $1.1 million in Q4 2025, and $25.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 329.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -49.35 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -363.46 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3.17 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 24.51 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -229.72 Mn
10 Nkarta 201.14 Mn 201.14 Mn - 21.15 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 21.15 Mn
Jun 30, 2026 21.15 Mn
Mar 31, 2026 15.92 Mn
Mar 31, 2026 15.92 Mn
Dec 31, 2025 1.10 Mn
Dec 31, 2025 1.10 Mn
Sep 30, 2025 25.39 Mn
Sep 30, 2025 25.39 Mn
Jun 30, 2025 19.49 Mn
Jun 30, 2025 19.49 Mn
Mar 31, 2025 54.34 Mn
Mar 31, 2025 54.34 Mn
Dec 31, 2024 -4.52 Mn
Dec 31, 2024 -4.52 Mn
Sep 30, 2024 -38.90 Mn
Sep 30, 2024 -38.90 Mn
Jun 30, 2024 -107.63 Mn
Jun 30, 2024 -107.63 Mn
Mar 31, 2024 21.49 Mn
Mar 31, 2024 21.49 Mn